DERMAPHARM HOLDING SE |
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 35,8 EUR | -0,56 % |
|
-3,50 % | -15,45 % |
| 27/06 | Dermapharm Holding SE donne des prévisions de résultats pour l'année 2024 | CI |
| 06/06 | Jefferies abaisse l'objectif de Dermapharm à 51 euros - 'Acheter'. | DP |
Métier
Nombre d'employés: 3 497
Ventes par activité
| EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Branded Medicine
46,9
%
| - | - | 533 | 46,9 % | - |
Other Health Products
32,7
%
| - | - | 372 | 32,7 % | - |
Parallel Import
20,3
%
| 253 | 24,7 % | 231 | 20,3 % | -8,92 % |
Ventes par région
| EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Germany
62,3
%
| 1 025 | 100,0 % | 707 | 62,3 % | -31,01 % |
France
13,4
%
| - | - | 152 | 13,4 % | - |
Spain
10,4
%
| - | - | 118 | 10,4 % | - |
Other
7,9
%
| - | - | 90 | 7,9 % | - |
Austria / Switzerland
6,0
%
| - | - | 69 | 6,0 % | - |
Dirigeants
| Dirigeants | Titre | Age | Depuis |
|---|---|---|---|
| Chief Executive Officer | 62 | 01/08/17 | |
| Director of Finance/CFO | - | 01/11/22 | |
Britta Hamberger
IRC | Investor Relations Contact | - | 01/12/18 |
Andreas Eberhorn
SAM | Sales & Marketing | 49 | 01/09/22 |
Administrateurs
| Administrateurs | Titre | Age | Depuis |
|---|---|---|---|
| Director/Board Member | 75 | 01/01/18 | |
Wilhelm Beier
CHM | Chairman | 68 | 01/08/17 |
Erwin Kern
BRD | Director/Board Member | 64 | 01/08/17 |
Classe d'actions
| Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
|---|---|---|---|---|---|
| Action A | 1 | 53 840 000 | 17 368 784 ( 32,26 %) | 0 | 32,26 % |
Coordonnées société
Sociétés du groupe
| Nom | Catégorie et Secteur |
|---|---|
mibe GmbH
 mibe GmbH Pharmaceuticals: MajorHealth Technology mibe GmbH manufactures pharmaceuticals products. The company was founded in 2001 and is headquartered in Brehna, Germany |
Pharmaceuticals: Major
|
Dermapharm AG
 Dermapharm AG Pharmaceuticals: MajorHealth Technology Dermapharm AG engages in the development, production, and distribution of dermatological and allergological products. It offers pharmaceutical articles used for alopecia, allergies, skin- and healthcare, osteoporosis, mycosis, wounds, as well as vein ailments. The company was founded in 1991 and is headquartered in Gruenwald, Germany. |
Pharmaceuticals: Major
|
Strathmann GmbH & Co. KG
 Strathmann GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Strathmann GmbH & Co. KG engages in the manufacture and distribution of pharmaceutical products. It offers muscle relaxants, dermatics, analgesics and anti-inflammatory drugs, antirheumatics, mineral preparations, osteoporosis agents and vaccines, as well as immunomodulators. The company was founded by Detlef Strathmann in 1974 and is headquartered in Hamburg, Germany. |
Pharmaceuticals: Major
|
Dermapharm AG (Switzerland)
| |
Euromed SA (Spain)
 Euromed SA (Spain) Pharmaceuticals: OtherHealth Technology Euromed SA engages in the production of herbal extracts and natural active substances. It offers artichoke, echinacea, ginseng, hawthorn, nettle, milk thistle, and valerian products. The firm specializes in pharmaceutical, health, food, and cosmetic industries. The company was founded on July 13, 1971 and is headquartered in Mollet del Valles, Spain. |
Pharmaceuticals: Other
|
Allergopharma AG
 Allergopharma AG Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Allergopharma AG is a Swiss company that manufactures and distributes hypoallergenic immunotherapy products. The company is located in Switzerland. |
Pharmaceuticals: Major
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
| Varia. 1 janv. | Capi. | |
|---|---|---|
| -15,45 % | 2,11 Md | |
| +63,05 % | 854 Md | |
| +39,42 % | 636 Md | |
| -4,78 % | 361 Md | |
| +17,52 % | 324 Md | |
| +8,43 % | 301 Md | |
| +14,19 % | 247 Md | |
| +5,81 % | 230 Md | |
| +16,77 % | 228 Md | |
| +14,63 % | 177 Md |
- Bourse
- Actions
- Action DMP
- Société Dermapharm Holding SE
